Geode Capital Management, LLC Vaccinex, Inc. Transaction History

Geode Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.44 - $131.17 $305 - $91,031	-694 Reduced 0.28%	250,186 $164,000
Q3 2022 Nov 14, 2022	BUY	$0.48 - $109.22 $905 - $206,098	1,887 Added 0.76%	250,880 $124,000
Q2 2022 Aug 12, 2022	BUY	$1.05 - $1.39 $12,891 - $17,066	12,278 Added 5.19%	248,993 $268,000
Q1 2022 May 13, 2022	BUY	$0.92 - $1.94 $99,712 - $210,263	108,383 Added 84.46%	236,715 $312,000
Q3 2021 Nov 12, 2021	BUY	$2.11 - $2.81 $51,099 - $68,052	24,218 Added 23.26%	128,332 $277,000
Q2 2021 Aug 13, 2021	BUY	$2.01 - $3.0 $77,953 - $116,349	38,783 Added 59.36%	104,114 $291,000
Q1 2021 May 12, 2021	BUY	$2.09 - $5.11 $136,541 - $333,841	65,331 New	65,331 $194,000

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $158M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.